UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The impacts of carbon emission trading mechanism on the power transition pathway -taking Guangdong-Hong Kong-Macao Greater Bay Area as an example

Journal of cleaner production, 2022-01, Vol.330, p.129894, Article 129894

2022

Volltextzugriff (PDF)

Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma

Cancer letters, 2020-06, Vol.479, p.31-41

2020

Volltextzugriff (PDF)

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China

Journal of cancer research and clinical oncology, 2022-04, Vol.148 (4), p.943-954

2022

Volltextzugriff (PDF)

Nivolumab plus ipilimumab: a potential regimen to rewrite treatment guidelines for ESCC

Signal transduction and targeted therapy, 2022-05, Vol.7 (1), p.169-169, Article 169

2022

Volltextzugriff (PDF)

Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma

Oncoimmunology, 2020-01, Vol.9 (1), p.1824641-1824641

2020

Volltextzugriff (PDF)

Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma

EBioMedicine, 2020-09, Vol.59, p.102959-102959, Article 102959

2020

Volltextzugriff (PDF)

m6A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer

Journal of hematology and oncology, 2021-11, Vol.14 (1), p.1-190, Article 190

2021

Volltextzugriff (PDF)

Comprehensive analyses of N6‐methyladenosine‐related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer

Cancer science, 2022-12, Vol.113 (12), p.4289-4299

2022

Volltextzugriff (PDF)

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma

Journal of translational medicine, 2022-07, Vol.20 (1), p.1-332, Article 332

2022

Volltextzugriff (PDF)

Tumor Necrosis Factor Family Member Profile Predicts Prognosis and Adjuvant Chemotherapy Benefit for Patients With Small-Cell Lung Cancer

Frontiers in immunology, 2021-11, Vol.12, p.745769

2021

Volltextzugriff (PDF)

The landscape of m6A regulators in small cell lung cancer: molecular characteristics, immuno-oncology features, and clinical relevance

Molecular cancer, 2021-09, Vol.20 (1), p.1-122, Article 122

2021

Volltextzugriff (PDF)

m6A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer

BMC medicine, 2021-11, Vol.19 (1), p.1-284, Article 284

2021

Volltextzugriff (PDF)

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer

Cancer cell international, 2021-12, Vol.21 (1), p.691-691, Article 691

2021

Volltextzugriff (PDF)

An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma

Signal transduction and targeted therapy, 2020-09, Vol.5 (1), p.182-182, Article 182

2020

Volltextzugriff (PDF)

Making the Best Use of Available Weapons for the Inevitable Rivalry-Resistance to EGFR-TKIs

Biomedicines, 2023-04, Vol.11 (4), p.1141

2023

Volltextzugriff (PDF)

Single-cell analysis reveals the potential mechanisms of pyrotinib resistance in non-small cell lung cancer

Signal transduction and targeted therapy, 2023-01, Vol.8 (1), p.17-17, Article 17

2023

Volltextzugriff (PDF)

RNA N6‐methyladenosine modification in the lethal teamwork of cancer stem cells and the tumor immune microenvironment: Current landscape and therapeutic potential

Clinical and translational medicine, 2021-09, Vol.11 (9), p.e525-n/a

2021

Volltextzugriff (PDF)

The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma

Genes & diseases, 2022-03, Vol.9 (2), p.415-428

2022

Volltextzugriff (PDF)

Tumor‐infiltrating CD8+ T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma

Clinical and translational medicine, 2021-06, Vol.11 (6), p.e456-n/a

2021

Volltextzugriff (PDF)

The impact of emission trading schemes on firm competitiveness: Evidence of the mediating effects of firm behaviors from the guangdong ETS

Journal of environmental management, 2021-07, Vol.290, p.112633-112633, Article 112633

2021

Volltextzugriff (PDF)

A three‐lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy

Clinical and translational medicine, 2020-08, Vol.10 (4), p.e156-n/a

2020

Volltextzugriff (PDF)

Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes

Frontiers in cell and developmental biology, 2020-12, Vol.8, p.580005-580005

2020

Volltextzugriff (PDF)

The key elements analysis of Guangdong & Shenzhen ETS & tips for China national ETS construction

Chinese Journal of Population Resources and Environment, 2016-10, Vol.14 (4), p.282-291

2016

Volltextzugriff (PDF)

The potential role of N7-methylguanosine (m7G) in cancer

Journal of hematology and oncology, 2022-05, Vol.15 (1), p.1-63, Article 63

2022

Volltextzugriff (PDF)

Utilizing MapReduce to Improve Probe-Car Track Data Mining

ISPRS international journal of geo-information, 2018-07, Vol.7 (7), p.287

2018

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(129)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The impacts of carbon emission trading mechanism on the power transition pathway -taking Guangdong-Hong Kong-Macao Greater Bay Area as an example

Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China

Nivolumab plus ipilimumab: a potential regimen to rewrite treatment guidelines for ESCC

Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma

Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma

m6A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer

Comprehensive analyses of N6‐methyladenosine‐related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma

Tumor Necrosis Factor Family Member Profile Predicts Prognosis and Adjuvant Chemotherapy Benefit for Patients With Small-Cell Lung Cancer

The landscape of m6A regulators in small cell lung cancer: molecular characteristics, immuno-oncology features, and clinical relevance

m6A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer

An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma

Making the Best Use of Available Weapons for the Inevitable Rivalry-Resistance to EGFR-TKIs

Single-cell analysis reveals the potential mechanisms of pyrotinib resistance in non-small cell lung cancer

RNA N6‐methyladenosine modification in the lethal teamwork of cancer stem cells and the tumor immune microenvironment: Current landscape and therapeutic potential

The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma

Tumor‐infiltrating CD8+ T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma

The impact of emission trading schemes on firm competitiveness: Evidence of the mediating effects of firm behaviors from the guangdong ETS

A three‐lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy

Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes

The key elements analysis of Guangdong & Shenzhen ETS & tips for China national ETS construction

The potential role of N7-methylguanosine (m7G) in cancer

Utilizing MapReduce to Improve Probe-Car Track Data Mining

Suchergebnisse filtern